Nuvectis Pharma, Inc. (NVCT)
NVCT Stock Price Chart
Explore Nuvectis Pharma, Inc. interactive price chart. Choose custom timeframes to analyze NVCT price movements and trends.
NVCT Company Profile
Discover essential business fundamentals and corporate details for Nuvectis Pharma, Inc. (NVCT) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
4 Feb 2022
Employees
13.00
Website
https://www.nuvectis.comCEO
Ron Bentsur
Description
Nuvectis Pharma, Inc. operates as a biopharmaceutical firm specializing in the development of targeted therapies to address critical, unmet needs within the field of oncology. The company's innovative pipeline features NXP800, a novel compound engineered to inhibit the heat shock factor 1 pathway for treating various forms of cancer. Another promising asset is NXP900, a small molecule drug candidate crafted to suppress the Proto-oncogene c-Src and YES1 kinases. This Fort Lee, New Jersey-based organization was established in 2020.
NVCT Financial Timeline
Browse a chronological timeline of Nuvectis Pharma, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 4 Aug 2026
EPS estimate is -$0.25.
Earnings released on 5 May 2026
EPS came in at -$0.26 surpassing the estimated -$0.30 by +13.33%.
Earnings released on 11 Feb 2026
EPS came in at -$0.31 falling short of the estimated -$0.26 by -19.23%.
Earnings released on 4 Nov 2025
EPS came in at -$0.44 falling short of the estimated -$0.24 by -83.33%.
Earnings released on 5 Aug 2025
EPS came in at -$0.30 falling short of the estimated -$0.25 by -20.00%.
Earnings released on 6 May 2025
EPS came in at -$0.27 surpassing the estimated -$0.30 by +10.00%.
Earnings released on 25 Feb 2025
EPS came in at -$0.36 falling short of the estimated -$0.28 by -28.57%.
Earnings released on 5 Nov 2024
EPS came in at -$0.24 surpassing the estimated -$0.26 by +7.69%.
Earnings released on 6 Aug 2024
EPS came in at -$0.26 matching the estimated -$0.26.
Earnings released on 7 May 2024
EPS came in at -$0.25 surpassing the estimated -$0.40 by +37.50%.
Earnings released on 5 Mar 2024
EPS came in at -$0.41 falling short of the estimated -$0.40 by -2.50%, while revenue for the quarter reached -$4.10m .
Earnings released on 8 Nov 2023
EPS came in at -$0.37 surpassing the estimated -$0.38 by +2.63%.
Earnings released on 9 Aug 2023
EPS came in at -$0.38 falling short of the estimated -$0.34 by -11.76%.
Earnings released on 10 May 2023
EPS came in at -$0.27 surpassing the estimated -$0.44 by +38.64%, while revenue for the quarter reached $4.10m .
Earnings released on 7 Mar 2023
EPS came in at -$0.48 falling short of the estimated -$0.38 by -26.32%, while revenue for the quarter reached $149.00k .
Earnings released on 8 Nov 2022
EPS came in at -$0.42 falling short of the estimated -$0.27 by -55.56%.
Earnings released on 5 Aug 2022
EPS came in at -$0.28 falling short of the estimated -$0.24 by -16.67%, while revenue for the quarter reached -$140.00 .
Earnings released on 10 May 2022
EPS came in at -$0.32 falling short of the estimated -$0.23 by -39.13%.
Earnings released on 7 Feb 2022
EPS came in at -$0.18 surpassing the estimated -$0.85 by +79.08%, while revenue for the quarter reached $4.00k .
Earnings released on 14 Jan 2022
EPS came in at -$0.40 .
NVCT Stock Performance
Access detailed NVCT performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
